Research graph
References from Epidemiology and health burden of infective endocarditis: a comparative analysis of Australian vs global trends from 1990 to 2021. Local targets link to admitted publications; unresolved targets remain external evidence.
The 2023 Duke‐International Society for Cardiovascular Infectious Diseases Criteria for infective endocarditis: updating the modified Duke criteria
10.1093/cid/ciad271 · 2023 · External reference
2023 ESC Guidelines for the management of endocarditis: developed by the task force on the management of endocarditis of the European Society of Cardiology (ESC) endorsed by the European Association for Cardio‐Thoracic Surgery (EACTS) and the European Association of Nuclear Medicine (EANM)
10.1093/eurheartj/ehad193 · 2023 · External reference
Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications
10.1161/cir.0000000000000296 · 2015 · External reference
2015 ESC guidelines on the management of infective endocarditis: a big step forward for an old disease
10.1136/heartjnl-2015-308791 · 2016 · External reference
Global incidence, prevalence, years lived with disability (YLDs), disability‐adjusted life‐years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021
10.1016/s0140-6736(24)00757-8 · 2024 · External reference
Recommendations on nuclear and multimodality imaging in IE and CIED infections
10.1007/s00259-018-4025-0 · 2018 · External reference
Surgical outcomes of infective endocarditis among intravenous drug users
10.1016/j.jtcvs.2016.02.072 · 2016 · External reference
Long‐term outcome of infective endocarditis in non‐intravenous drug users
10.4065/83.11.1213 · 2008 · External reference
Global burden of cardiovascular diseases and risks, 1990–2022
10.1016/j.jacc.2023.11.007 · 2023 · External reference
Long‐term outcomes are poor in intravenous drug users following infective endocarditis, even after surgery
10.1093/cid/ciz869 · 2019 · External reference
The epidemiology of infective endocarditis in New South Wales, Australia: a retrospective cross‐sectional study from 2001 to 2020
10.1016/j.hlc.2022.12.002 · 2023 · External reference
Infective endocarditis in the intravenous drug use population at a tertiary Hospital in Melbourne, Australia
10.1016/j.hlc.2018.12.016 · 2020 · External reference
Infective endocarditis outcomes at a tertiary hospital in Western Australia: a retrospective cohort study from 2016 to 2021
10.1111/imj.16508 · 2024 · External reference
Burden of infective endocarditis in an Australian cohort of people who inject drugs
10.1111/imj.14717 · 2020 · External reference
The current epidemiology of injecting drug use‐associated infective endocarditis in Victoria, Australia in the midst of increasing crystal methamphetamine use
10.1016/j.hlc.2017.03.166 · 2018 · External reference
Unresolved reference
2021 · External reference
Unresolved reference
2021 · External reference
Unresolved reference
External reference
Guidelines for accurate and transparent health estimates reporting: the GATHER statement
10.1016/s0140-6736(16)30388-9 · 2016 · External reference
Growth and geographical variation in the use of cardiac imaging in Australia
10.1111/imj.12867 · 2015 · External reference
Clinical outcomes of infective endocarditis in injection drug users
10.1016/j.jacc.2018.10.082 · 2019 · External reference
Prospective cohort study of infective endocarditis in people who inject drugs
10.1016/j.jacc.2020.11.062 · 2021 · External reference
Epidemiology of acute infections in people who inject drugs in Australia
10.1111/dar.13772 · 2024 · External reference
The 2020 Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease
10.5694/mja2.50851 · 2021 · External reference
Ending rheumatic heart disease in Australia: the evidence for a new approach
10.5694/mja2.50853 · 2020 · External reference
Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure
10.1001/jama.2011.1701 · 2011 · External reference
Characteristics and outcome of acute heart failure in infective endocarditis: focus on cardiogenic shock
10.1093/cid/ciab098 · 2021 · External reference
The cardiac complications of methamphetamines
10.1016/j.hlc.2015.10.019 · 2016 · External reference
A comprehensive approach to managing methamphetamine‐associated cardiomyopathy
10.1007/s40256-022-00523-y · 2022 · External reference
High readmission rates and mental distress after infective endocarditis ‐ results from the national population‐based CopenHeart IE survey
10.1016/j.ijcard.2017.02.077 · 2017 · External reference
Infective endocarditis and thoracic aortic disease: a review on forgotten psychological aspects
10.4330/wjc.v9.i7.620 · 2017 · External reference
2023 ESC guidelines for the management of acute coronary syndromes: developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)
10.1093/eurheartj/ehad191 · 2023 · External reference
Infective endocarditis: a hunter New England perspective
10.1111/imj.13797 · 2018 · External reference
Infective endocarditis
10.1016/j.hlc.2014.02.010 · 2014 · External reference
Outcomes of surgically treated infective endocarditis in a Western Australian population
10.1186/s13019-021-01727-0 · 2021 · External reference
Infective endocarditis: a contemporary study of microbiology, echocardiography and associated clinical outcomes at a major tertiary referral Centre
10.1016/j.hlc.2019.07.006 · 2020 · External reference
Surgical management and mid‐term outcomes of 108 patients with infective endocarditis
10.1016/j.hlc.2011.03.013 · 2011 · External reference
Health care exposure and age in infective endocarditis: results of a contemporary population‐based profile of 1536 patients in Australia
10.1093/eurheartj/ehq110 · 2010 · External reference
Sex differences in the utilization and outcomes of cardiac valve replacement surgery for infective endocarditis: insights from the National Inpatient Sample
10.1161/jaha.120.020095 · 2021 · External reference
Analysis of sex differences in the clinical presentation, management and prognosis of infective endocarditis in Spain
10.1136/heartjnl-2021-319254 · 2021 · External reference
Impact of referral bias on prognostic studies outcomes: insights from a population‐based cohort study on infective endocarditis
10.1016/j.annepidem.2020.09.008 · 2021 · External reference
Severity of presentation, not sex, increases risk of surgery for infective endocarditis
10.1016/j.athoracsur.2018.10.033 · 2019 · External reference
Exploring sex differences in infective endocarditis ‐ a prospective, observational study from Western Norway
10.1186/s12872-025-04631-w · 2025 · External reference
Sex differences in infective endocarditis: a systematic review
2023 · External reference
